CXCR2 and ovarian carcinoma: A study of CXCR1 and CXCR2 activation by IL-8 and inhibition by reparixin confirmed that CXCR2 was primarily present on ovarian cancer cells, and its high expression was strongly associated with shorter survival and increased metastatic potential [60].